SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-167607
Filing Date
2014-04-29
Accepted
2014-04-29 17:15:25
Documents
10
Period of Report
2014-06-05
Effectiveness Date
2014-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d720497ddef14a.htm DEF 14A 686176
2 GRAPHIC g720497g90x18.jpg GRAPHIC 5746
3 GRAPHIC g720497img1.jpg GRAPHIC 8560
4 GRAPHIC g720497pc001a.jpg GRAPHIC 39397
5 GRAPHIC g720497pc001c.jpg GRAPHIC 4187
6 GRAPHIC g720497pc001d.jpg GRAPHIC 15374
7 GRAPHIC g720497pc_001b.jpg GRAPHIC 41282
8 GRAPHIC g720497pc_001f.jpg GRAPHIC 39350
9 GRAPHIC g720497sig_001.jpg GRAPHIC 5970
10 GRAPHIC g720497sig_002.jpg GRAPHIC 8520
  Complete submission text file 0001193125-14-167607.txt   920636
Mailing Address 320 BENT STREET CAMBRIDGE MA 02141
Business Address 320 BENT STREET CAMBRIDGE MA 02141 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-49839 | Film No.: 14794938
SIC: 2834 Pharmaceutical Preparations